Literature DB >> 7982936

Enzymatic synthesis and characterizations of cyclic GDP-ribose. A procedure for distinguishing enzymes with ADP-ribosyl cyclase activity.

R M Graeff1, T F Walseth, K Fryxell, W D Branton, H C Lee.   

Abstract

Cyclic nucleotides such as cAMP and cGMP are second messengers subserving various signaling pathways. Cyclic ADP-ribose (cADPR), a recently discovered member of the family, is derived from NAD+ and is a mediator of Ca2+ mobilization in various cellular systems. The synthesis and degradation of cADPR are, respectively, catalyzed by ADP-ribosyl cyclase and cADPR hydrolase. CD38, a differentiation antigen of B lymphocytes, has recently been shown to be a bifunctional enzyme catalyzing both the formation and hydrolysis of cADPR. The overall reaction catalyzed by CD38 is the formation of ADP-ribose and nicotinamide from NAD+, identical to that catalyzed by NADase. The difficulties in detecting the formation of cADPR have led to frequent identification of CD38 as a classical NADase. In this study, we show that both ADP-ribosyl cyclase and CD38, but not NADase, can cyclize nicotinamide guanine dinucleotide (NGD+) producing a new nucleotide. Analyses by high performance liquid chromatography and mass spectroscopy indicate the product is cyclic GDP-ribose (cGDPR) with a structure similar to cADPR except with guanine replacing adenine. Compared to cADPR, cGDPR is a more stable compound showing 2.8 times more resistance to heat-induced hydrolysis. These results are consistent with a catalytic scheme for CD38 where the cyclization of the substrate precedes the hydrolytic reaction. Spectroscopic analyses show that cGDPR is fluorescent and has an absorption spectrum different from both NGD+ and GDPR, providing a very convenient way for monitoring its enzymatic formation. The use of NGD+ as substrate for assaying the cyclization reaction was found to be applicable to pure enzymes as well as crude tissue extracts making it a useful diagnostic tool for distinguishing CD38-like enzymes from degradative NADases.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7982936

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  59 in total

1.  Nitric oxide and cGMP activate Ca2+-release processes in rat parotid acinar cells.

Authors:  D K Looms; K Tritsaris; B Nauntofte; S Dissing
Journal:  Biochem J       Date:  2001-04-01       Impact factor: 3.857

2.  Kinetic competence of the cADP-ribose-CD38 complex as an intermediate in the CD38/NAD+ glycohydrolase-catalysed reactions: implication for CD38 signalling.

Authors:  C Cakir-Kiefer; H Muller-Steffner; N Oppenheimer; F Schuber
Journal:  Biochem J       Date:  2001-09-01       Impact factor: 3.857

3.  Site-directed removal of N-glycosylation sites in BST-1/CD157: effects on molecular and functional heterogeneity.

Authors:  S Yamamoto-Katayama; A Sato; M Ariyoshi; M Suyama; K Ishihara; T Hirano; H Nakamura; K Morikawa; H Jingami
Journal:  Biochem J       Date:  2001-07-15       Impact factor: 3.857

4.  Porcine CD38 exhibits prominent secondary NAD(+) cyclase activity.

Authors:  Kai Yiu Ting; Christina F P Leung; Richard M Graeff; Hon Cheung Lee; Quan Hao; Masayo Kotaka
Journal:  Protein Sci       Date:  2016-01-12       Impact factor: 6.725

5.  Cellular effects and metabolic stability of N1-cyclic inosine diphosphoribose and its derivatives.

Authors:  T Kirchberger; G Wagner; J Xu; C Cordiglieri; P Wang; A Gasser; R Fliegert; S Bruhn; A Flügel; F E Lund; L-H Zhang; B V L Potter; A H Guse
Journal:  Br J Pharmacol       Date:  2006-09-11       Impact factor: 8.739

6.  TIR Domain Proteins Are an Ancient Family of NAD+-Consuming Enzymes.

Authors:  Kow Essuman; Daniel W Summers; Yo Sasaki; Xianrong Mao; Aldrin Kay Yuen Yim; Aaron DiAntonio; Jeffrey Milbrandt
Journal:  Curr Biol       Date:  2018-01-25       Impact factor: 10.834

7.  Channelling of substrate promiscuity of the skeletal-muscle ADP-ribosyl cyclase isoform.

Authors:  Ingrid Bacher; Andreas Zidar; Martin Kratzel; Martin Hohenegger
Journal:  Biochem J       Date:  2004-07-01       Impact factor: 3.857

Review 8.  CD38 as a regulator of cellular NAD: a novel potential pharmacological target for metabolic conditions.

Authors:  Eduardo Nunes Chini
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

9.  Dual role of CD38 in microglial activation and activation-induced cell death.

Authors:  Lior Mayo; Jasmine Jacob-Hirsch; Ninette Amariglio; Gideon Rechavi; Marie-Jo Moutin; Frances E Lund; Reuven Stein
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

10.  Molecular characterization of a novel cell surface ADP-ribosyl cyclase from the sea urchin.

Authors:  Dev Churamani; Michael J Boulware; Latha Ramakrishnan; Timothy J Geach; Andrew C R Martin; Victor D Vacquier; Jonathan S Marchant; Leslie Dale; Sandip Patel
Journal:  Cell Signal       Date:  2008-09-13       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.